The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2015

Filed:

Oct. 18, 2007
Applicants:

Steven C. Quay, Woodinville, WA (US);

James Mcswiggen, Bothell, WA (US);

Narendra K. Vaish, Kirkland, WA (US);

Mohammad Ahmadian, Bothell, WA (US);

Inventors:

Steven C. Quay, Woodinville, WA (US);

James Mcswiggen, Bothell, WA (US);

Narendra K. Vaish, Kirkland, WA (US);

Mohammad Ahmadian, Bothell, WA (US);

Assignee:

Marina Biotech, Inc., New York, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); C07H 21/04 (2006.01); A61K 48/00 (2006.01); C12N 15/11 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/111 (2013.01); A61K 38/00 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2320/51 (2013.01); C12N 2330/30 (2013.01);
Abstract

The present disclosure provides meroduplex (nicked or gapped) ribonucleic acid molecules (mdRNA) that decreases or silences target gene expression. An mdRNA of this disclosure comprises at least three strands that combine to form at least two non-overlapping double-stranded regions separated by a nick or gap wherein one strand is complementary to a target gene RNA. In addition, the meroduplex may have one or more modifications or substitutions, such as nucleotide base, sugar, terminal cap structure, internucleotide linkage, or any combination of such modifications. Also provided are methods of decreasing expression of a target gene in a cell or in a subject to treat a disease related to altered expression of a target gene.


Find Patent Forward Citations

Loading…